For: | Michelin AP, Maes MHJ, Supasitthumrong T, Limotai C, Matsumoto AK, de Oliveira Semeão L, de Lima Pedrão JV, Moreira EG, Kanchanatawan B, Barbosa DS. Reduced paraoxonase 1 activities may explain the comorbidities between temporal lobe epilepsy and depression, anxiety and psychosis. World J Psychiatry 2022; 12(2): 308-322 [PMID: 35317335 DOI: 10.5498/wjp.v12.i2.308] |
---|---|
URL: | https://www.wjgnet.com/2220-3206/full/v12/i2/308.htm |
Number | Citing Articles |
1 |
Michael Maes, Décio Sabbatini Barbosa, Abbas F. Almulla, Buranee Kanchanatawan. A Novel Pathway Phenotype of Temporal Lobe Epilepsy and Comorbid Psychiatric Disorders: Results of Precision Nomothetic Medicine. Antioxidants 2022; 11(5): 803 doi: 10.3390/antiox11050803
|
2 |
Francis F. Brinholi, Ana Paula Michelin, Andressa K. Matsumoto, Laura de O Semeão, Abbas F. Almulla, Thitiporn Supasitthumrong, Chavit Tunvirachaisakul, Décio S. Barbosa, Michael Maes. Paraoxonase 1 status is a major Janus-faced component of mild and moderate acute ischemic stroke and consequent disabilities. Metabolic Brain Disease 2023; 38(6): 2115 doi: 10.1007/s11011-023-01232-4
|
3 |
Michael HJ Maes, Drozdstoy Stoyanov. False dogmas in mood disorders research: Towards a nomothetic network approach. World Journal of Psychiatry 2022; 12(5): 651-667 doi: 10.5498/wjp.v12.i5.651
|